Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

stat rx usa llc - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 400 mg - neurontin (gabapentin) is indicated for the management of postherpetic neuralgia in adults. neurontin (gabapentin) is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. neurontin is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 – 12 years. neurontin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. the abuse and dependence potential of neurontin has not been evaluated in human studies.

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

parke-davis div of pfizer inc - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - gabapentin 100 mg - neurontin® is indicated for: neurontin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as neurontin, during pregnancy. encourage women who are taking neurontin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of neurontin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal and visceral abnormalities, and increased embryofetal mortality) when administered to pregnant animals at doses similar to or lower than those used clinically [see data]. in the u.s. general population, the estimated background

Australija - engleski - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - gabapentin, quantity: 100 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; purified talc; titanium dioxide; gelatin; indigo carmine; ethanol; butan-1-ol; shellac; methanol - neurontin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children aged 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. neurontin is indicated for the treatment of neuropathic pain

Australija - engleski - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - gabapentin, quantity: 300 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; purified talc; gelatin; titanium dioxide; iron oxide yellow; indigo carmine; ethanol; butan-1-ol; shellac; methanol - neurontin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children aged 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. neurontin is indicated for the treatment of neuropathic pain

Australija - engleski - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - gabapentin, quantity: 400 mg - capsule, hard - excipient ingredients: lactose monohydrate; maize starch; purified talc; gelatin; titanium dioxide; iron oxide yellow; iron oxide red; indigo carmine; ethanol; butan-1-ol; shellac; methanol - neurontin is indicated for the treatment of partial seizures, including secondarily generalised tonic-clonic seizures, initially as add-on therapy in adults and children aged 3 years and above who have not achieved adequate control with standard anti-epileptic drugs. neurontin is indicated for the treatment of neuropathic pain

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

remedyrepack inc. - gabapentin (unii: 6cw7f3g59x) (gabapentin - unii:6cw7f3g59x) - neurontin ® is indicated for: - management of postherpetic neuralgia in adults - adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy neurontin is contraindicated in patients who have demonstrated hypersensitivity to the drug or its ingredients. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to antiepileptic drugs (aeds), such as neurontin, during pregnancy. encourage women who are taking neurontin during pregnancy to enroll in the north american antiepileptic drug (naaed) pregnancy registry by calling the toll free number 1-888-233-2334 or visiting http://www.aedpregnancyregistry.org/. risk summary there are no adequate data on the developmental risks associated with the use of neurontin in pregnant women. in nonclinical studies in mice, rats, and rabbits, gabapentin was developmentally toxic (increased fetal skeletal and

Bangladeš - engleski - DGDA (Directorate General of Drug Administration)

neuron drug laboratories (unani) - sharbat faulad - liquid

Bangladeš - engleski - DGDA (Directorate General of Drug Administration)

neuron drug laboratories (unani) - sharbat ejaz - liquid

Bangladeš - engleski - DGDA (Directorate General of Drug Administration)

neuron drug laboratories (unani) - sharbat deenar - liquid

Bangladeš - engleski - DGDA (Directorate General of Drug Administration)

neuron drug laboratories (unani) - arq nankha - liquid